Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PRINCIPEN '125' vs PRINCIPEN '500'
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Treatment of infections caused by susceptible gram-positive and gram-negative bacteria, including respiratory tract infections, otitis media, sinusitis, urinary tract infections, meningitis, septicemia, and gastroenteritis.,Off-label: Prophylaxis for bacterial endocarditis, treatment of listeriosis, and Lyme disease.
Infections of the respiratory tract,Genitourinary tract infections,Meningitis,Septicemia,Endocarditis,Gastrointestinal infections,Skin and soft tissue infections,Prophylaxis for bacterial endocarditis (off-label)
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.
500 mg orally every 6 hours for 7-14 days for mild to moderate infections; for severe infections, 500 mg orally every 4 hours.
Terminal elimination half-life: 0.7-1.4 hours in adults with normal renal function. Prolonged in renal impairment (up to 7-10 hours in anuria).
0.5–1 hour; prolonged in renal impairment (up to 10 hours in anuria).
Ampicillin is metabolized by hydrolysis to penicilloic acid, primarily in the liver. It also undergoes renal tubular secretion.
Ampicillin is metabolized primarily by hydrolysis to penicilloic acid; hepatic metabolism is minimal.
Renal: approximately 60-80% of the dose excreted unchanged in urine via tubular secretion and glomerular filtration. Biliary/fecal: minimal, <10%.
Primarily renal (90% unchanged via glomerular filtration and tubular secretion); small amounts biliary/fecal (<5%).
Approximately 20-30% bound to serum proteins, primarily albumin.
~20% bound to serum albumin.
0.3-0.4 L/kg, approximating extracellular fluid volume. Higher in neonates and critically ill patients due to increased extracellular water.
0.2–0.3 L/kg; limited to extracellular fluid.
Oral: 30-50% due to acid lability and incomplete absorption. IM: nearly 100%.
IM: 100% (complete); PO: 30–60% (acid-labile, variable).
Cr Cl 10-50 m L/min: Administer every 6-12 hours. Cr Cl <10 m L/min: Administer every 12-16 hours.
For Cr Cl 30-50 m L/min: administer 500 mg every 8 hours; Cr Cl 10-30 m L/min: 500 mg every 12 hours; Cr Cl <10 m L/min: 500 mg every 24 hours.
No dose adjustment required.
No specific adjustment required for hepatic impairment; caution in severe hepatic disease due to potential risk of crystalluria.
Infants and children: 12.5-25 mg/kg orally every 6 hours. For severe infections: up to 50 mg/kg/day in divided doses every 6 hours.
For children >1 month: 12.5-25 mg/kg/dose orally every 6 hours; maximum 2 g/day. For neonates: 25 mg/kg/dose every 8 hours.
Dose based on renal function; use lower end of dosing interval due to age-related decline in renal function.
Adjust based on renal function; monitor for crystalluria and superinfection; standard dosing if Cr Cl >50 m L/min.
No FDA black box warning.
No FDA black box warning.
Serious and occasionally fatal hypersensitivity reactions (anaphylaxis) have occurred.,Clostridium difficile-associated diarrhea (CDAD) reported with nearly all antibacterial agents.,Prolonged use may result in overgrowth of nonsusceptible organisms including fungi.,Dosage adjustment required in renal impairment.,Safety in pregnancy: Category B; use only if clearly needed.
Serious hypersensitivity reactions (anaphylaxis) may occur,Clostridium difficile-associated diarrhea (CDAD),Seizures may occur in patients with renal impairment or high doses,Prolonged use may result in superinfection,Risk of bleeding abnormalities with high doses
Hypersensitivity to penicillins, cephalosporins, or other beta-lactam antibiotics.,Infections caused by beta-lactamase-producing organisms (ampicillin is susceptible to beta-lactamase degradation).
Hypersensitivity to ampicillin, penicillins, or any component of the formulation,Infections caused by beta-lactamase-producing organisms
Take on an empty stomach. Food, especially acidic beverages or fruit juices, may reduce absorption. Avoid alcohol concurrently. No specific dietary restrictions.
Avoid acidic beverages (e.g., fruit juices, soda) within 1 hour of taking ampicillin, as they may reduce absorption. Take on an empty stomach to maximize bioavailability. No specific dietary restrictions required.
FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Inadequate human data in first trimester; risk cannot be excluded. Penicillins are generally considered low risk throughout pregnancy.
Pregnancy Category B. Animal studies have not demonstrated fetal risk, but no adequate human studies in pregnant women. Use only if clearly needed. No evidence of teratogenicity in first trimester; theoretical risk of diarrhea or rash in neonates if administered near term.
Excreted into breast milk in low amounts (M/P ratio approximately 0.5). Considered compatible with breastfeeding; monitor infant for rash, diarrhea, or candidiasis.
Ampicillin is excreted into breast milk in low concentrations (M/P ratio ~0.05–0.2). Compatible with breastfeeding; may cause diarrhea or rash in infant. Monitor for gastrointestinal effects or sensitization.
No significant pharmacokinetic changes requiring dose adjustment. Increased renal clearance and expanded plasma volume may lower serum concentrations, but standard dosing remains effective. Adjust only if renal function significantly declines.
Physiologic changes in pregnancy (increased plasma volume, renal clearance) may reduce serum ampicillin concentrations; consider higher doses (e.g., 500 mg every 6 hours) for standard infections, but no specific dose adjustment recommendations exist. Monitor clinical response.
Principen '125' (ampicillin) is a broad-spectrum penicillin. Note that it is inactivated by beta-lactamases; use with a beta-lactamase inhibitor for resistant organisms. Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Monitor for hypersensitivity reactions, especially rash; ampicillin rash is common in patients with Epstein-Barr virus or concurrent allopurinol use. Adjust dose in renal impairment (Cr Cl <30 m L/min).
Principen '500' (ampicillin) is a penicillin-class antibiotic with activity against gram-positive cocci (except penicillinase-producing staphylococci) and some gram-negative bacilli. Use caution in patients with penicillin allergy; cross-reactivity with cephalosporins occurs in ~1% of cases. Monitor for rash, which can be maculopapular (commonly in patients with mononucleosis) or urticarial. Dose adjustment required in renal impairment (Cr Cl <30 m L/min). Administer on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Avoid concurrent use with allopurinol due to increased risk of ampicillin rash.
Take this medication on an empty stomach, at least 1 hour before or 2 hours after meals.,Complete the entire prescribed course even if you feel better.,Inform your doctor if you develop a rash, diarrhea, or signs of an allergic reaction.,Avoid alcohol while taking ampicillin to reduce side effects.,Use effective contraception if applicable; ampicillin may reduce oral contraceptive efficacy.
Take ampicillin exactly as prescribed, even if you feel better.,Take on an empty stomach (1 hour before or 2 hours after meals) with a full glass of water.,Finish the entire course of treatment; do not stop early unless directed by your doctor.,Inform your doctor if you have a penicillin allergy, kidney disease, or mononucleosis.,Contact your doctor if you develop severe diarrhea, rash, or difficulty breathing.,Ampicillin may reduce the effectiveness of oral contraceptives; use additional birth control methods.,Store at room temperature away from moisture and heat.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PRINCIPEN '125' vs PRINCIPEN '500', answered by our medical review team.
PRINCIPEN '125' is a Aminopenicillin Antibiotic that works by Ampicillin is a penicillin beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.. PRINCIPEN '500' is a Aminopenicillin Antibiotic that works by Ampicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PRINCIPEN '125' and PRINCIPEN '500' depend on the specific clinical indication. These are both Aminopenicillin Antibiotic agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PRINCIPEN '125' is: 250-500 mg orally every 6 hours for mild to moderate infections; 500 mg to 1 g every 6 hours for severe infections.. The standard adult dose of PRINCIPEN '500' is: 500 mg orally every 6 hours for 7-14 days for mild to moderate infections; for severe infections, 500 mg orally every 4 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PRINCIPEN '125' and PRINCIPEN '500' in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PRINCIPEN '125' is classified as Category C. FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. Inadequate human data in first trimester; risk cannot be excluded. Penicillins are generally considered l. PRINCIPEN '500' is classified as Category C. Pregnancy Category B. Animal studies have not demonstrated fetal risk, but no adequate human studies in pregnant women. Use only if clearly needed. No evidence of teratogenicity in. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.